Counselling parents about their child’s vaccinations (ages 0 through 6) : Developing an educational PowerPoint presentation for the EDUVAC project by Järvi, Heli & Tauriainen, Jasmiina
  
Heli Järvi, Jasmiina Tauriainen 
Counselling parents about their child’s 
vaccinations (ages 0 through 6) 
Developing an educational PowerPoint presentation for 
the EDUVAC project  
 Metropolia University of Applied Sciences 
Bachelor of Health Care 
Nursing and Health Care 
Thesis 
9.6.2020 
 Abstract 
 
Author(s) 
Title 
Heli Järvi, Jasmiina Tauriainen 
Counselling Parents about their Child’s Vaccinations (Ages 0 
Through 6) 
 
Number of Pages 
Date 
37 + 2 appendixes 
09 June 2020 
Degree Bachelor of Health Care 
Degree Programme Nursing and Health Care 
Specialisation option Nursing 
Instructor(s) PhD, Anne Nikula 
Immunization is an efficient and cost-effective way of preventing deaths globally. Health care 
professionals require ongoing education regarding immunization and thus, the purpose of 
this thesis is to enhance the vaccination competence of health care students. This thesis 
was done as part of the EDUVAC project which aims to improve the competence of health 
care students as vaccinators on an international scale. Therefore, the aim of this thesis was 
to create an educational video, for the EDUVAC project, about the counselling of parents of 
young children with their vaccinations. The final product will become part of the EDUVAC 
web-based course material. 
 
The method for this thesis included gathering scientific information on the different aspects 
of vaccination and counselling of parents of young children. Additionally, information gath-
ering was done on the aspects of a great quality educational video. Therefore, the script and 
the video were created based on accurate and appropriate information. The educational 
video for this thesis was supposed to mimic a real-life situation of parents bringing their one-
year old child into the health clinic for their scheduled vaccines. The filming was planned to 
be done in a simulation classroom where an authentic health care professional’s office was 
to be replicated. 
 
However, due to the COVID-19 pandemic, some alternations needed to be made for this 
thesis. The educational video was replaced by a PowerPoint presentation that includes pho-
tographs taken from a client counselling situation at the clients’ home. Hence, the presenta-
tion is the final product of this thesis and is included in the appendices. The presentation 
was created to help healthcare students gain better understanding and skills of client coun-
selling regarding the vaccination of a paediatric patient.  
Keywords Vaccination, vaccination competence, counselling, children, par-
ents, educational material 
Tiivistelmä 
 
Tekijä(t) 
Otsikko 
 
 
Sivumäärä 
Aika 
Heli Järvi ja Jasmiina Tauriainen  
Neuvolaikäisen Lapsen Vanhempien Ohjaus Rokotustilanteessa  
 
 
37 + 2 liitettä 
09 Kesäkuuta 2020 
Tutkinto Sairaanhoitaja AMK 
Tutkinto-ohjelma Hoitotyön koulutusohjelma 
Suuntautumisvaihtoehto Sairaanhoitotyö 
Ohjaaja(t) 
 TtT, Anne Nikula 
Rokottaminen on tehokas ja kustannustehokas tapa estää maailmanlaajuisesti kuolemia. 
Hoitotyön ammattilaiset tarvitsevat jatkuvaa koulutusta immunisaation lisäämiseksi rokotta-
misen kautta. Tämän opinnäytetyön tarkoituksena on kehittää hoitotyön opiskelijoiden roko-
tusosaamista. Opinnäytetyö tehtiin osana EDUVAC hanketta, jonka tarkoituksena on kehit-
tää ja lisätä hoitotyön opiskelijoiden ammatillista rokotusosaamista kansainvälisellä tasolla. 
Toiminnallisen opinnäytetyön tarkoituksena on opetusvideon luominen, jossa käydään läpi 
neuvolaikäisen lapsen vanhempien ohjaamista rokotustilanteessa.  
 
Opinnäytetyön menetelmiin kuului taustatiedon etsiminen rokotuksen eri aihealueista ja van-
hempien ohjauksesta. Lisäksi etsimme taustatietoa laadukkaan opetusvideon tekemisen kri-
teereistä. Näin ollen käsikirjoitus ja videon suunnitelma tehtiin tarkkaan tutkimustietoon pe-
rustaen. Opetusvideolla tilanteessa oli tarkoitus kuvata tosielämää vastaava tilanne, jossa 
vanhemmat saapuvat neuvolakäynnille yksivuotiaan lapsensa kanssa. Käynnillä on tarkoi-
tus antaa rokotusohjelma mukaiset rokotteet. Videolla oli tarkoitus esiintyä vanhemmat ja 
heidän yksivuotiaan lapsensa, ja terveydenhoitajana esiintyvä sairaanhoitajaopiskelija Ku-
vaaminen suunniteltiin toteutettavaksi simulaatio luokkatilassa, joka parhaiten vastaisi ter-
veydenhoitajan vastaanottoa. 
 
Vallitsevan COVID-19 pandemiatilanteen takia, opinnäytetyön suunnitelmia piti muokata ti-
lanteen sallimissa puitteissa. Opetusvideon kuvausta ei voitu toteuttaa koulujen sulkeudut-
tua, joten opetusvideo korvattiin PowerPoint esityksellä, johon liitimme valokuvia, jotka on 
otettu lavastetusta ohjaustilanteesta lapsen, vanhemman ja terveydenhoitajan välillä. Esi-
tyksen tarkoituksena on tarjota hoitotyön opiskelijoille kattavaa tietoa potilasohjauksesta, 
keskittyen erityisesti kommunikointiin vanhemman ja lapsen kanssa hoitokäynnillä, jossa on 
tarkoituksena antaa rokotteita lapsiasiakkaalle.  
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1 Introduction 
According to the World Health Organization (WHO) immunization is an important and 
efficient way of preventing deaths caused by life threatening diseases while also being 
cost effective. Public health care professionals require ongoing education concerning 
vaccinations in order to maintain proper procedures when vaccinating and providing pa-
tient guidance (Nikula, 2011, p. 15-16). The EDUVAC project works to improve the skills 
and vaccination competence of health care students on an international scale. One of 
the objectives is to develop a web-based course for educational purposes, and thus this 
thesis aims to produce material for this course. According to research, Finland’s orga-
nized vaccination program has allowed the vaccination coverage of the country to be at 
an excellent level. (THL, 2018, p.7.) Many of the vaccines included in the national vac-
cination program are given in the early years of life (THL, 2020a).  
The great importance of vaccines received in the early age of life makes the counselling 
of parents of young children extremely important. Therefore, the aim of this thesis is to 
collect information and knowledge about counselling of parents regarding the immuniza-
tion of their children. Furthermore, the aim is to produce an educational video where a 
real-life counselling situation is modelled. Additionally, it is important to gather knowledge 
on how children experience the vaccination procedure in order to provide valid infor-
mation on how to vaccinate the children accordingly and improve their experience. 
2 Aim and purpose of the Thesis 
The aim of this thesis is to provide educational video material for health care students 
about the vaccination of children (ages 0-6) and counselling of parents of those young 
children. Therefore, the purpose is to enhance health care students’ competence as vac-
cinators. Furthermore, this thesis aims to develop educational video material specifically 
for the EDUVAC program that these health care students will be participating during their 
studies. An educational video on the guidance of parents with children from ages 0 to 6 
will be produced and included in the EDUVAC web-course material. The aim is to create 
accurate and quality educational material and thus, the video will be produced by using 
empirical evidence gathered from different literary sources and official health promotion 
websites. 
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3 Description and purpose of the EDUVAC project  
The World Health Organization (2019) states, that vaccinations have been proven effec-
tive in decreasing deaths around the world while also being highly cost-effective. On 
average, immunization prevents about 2 to 3 million deaths per year that are caused by 
life threatening infectious diseases. (WHO, 2019). Vaccinations are administered by cer-
tified public health care professionals and thus, maintaining proper procedures requires 
ongoing education of vaccinators (Nikula, 2011, p. 15-16).  
The EDUVAC-project is about creating educational programs that will enhance the qual-
ity and relevance of the learning programs in vaccination at the partner institutions of the 
project. This is planned to happen via developing and implementing a web-based course 
and an intensive course to strengthen the knowledge, skills and attitudes of students at 
the universities about vaccination. The web-based course is set to be covering 3 ECTS 
and the Intensive Course worth 2 ETCS. These will provide students within the EU with 
valuable education on the attitudes, skills and knowledge regarding vaccinations. The 
EDUVCA-project will take time from 1st of September 2018 until the 31st of July 2021, 
with possible changes to the ending date. The participating partners in the project are all 
institutions of Higher Education from Greece, Finland, Slovakia, Spain and Italy and were 
chosen on the basis that they all educate students who will be health professionals hav-
ing vaccinations integrated into their study programs in different ways. (Nikula, 2018, p.1-
3.) 
The EDUVAC project aims to increase vaccination competence of health care students 
by improving the current educational program with the inclusion of international partner-
ship of other educational institutes in order to develop internationalized strategy regard-
ing vaccination competence. The project is planned to be done in co-operation of teach-
ers and professors from all the 5 institutions to produce the online material and arranging 
the Intensive Courses which are planned to happen two times. These courses are par-
ticipated by students from all the institutes and they will gain competences in the topic of 
the project. Students participating to the Intensive course will also gain experience and 
improve their skills in the English language as the whole project will be conducted in 
English. Some possibilities will also be offered to students to participate into the project 
with their final thesis and/or innovations projects with the chosen topics related to the 
EDUVAC-project. (Nikula, 2018, p.1-4.) 
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4 Different aspects of vaccination 
4.1 Vaccination in general 
Vaccination means the administration of a vaccine that often contains micro-organisms 
or viruses, or nowadays also other substances, in a killed or weakened state to improve 
and help the immune system in developing resistance to certain diseases. Vaccination 
is one of the most effective interventions in health promotion. (Nikula A. 2007, Herman-
son E. 2012, National Institute for Health and Welfare (THL), 2018.) It is a way of pre-
venting human beings of having to go through dangerous infectious diseases such as 
tuberculosis or measles. Vaccinations are meant to protect people. (National Institute for 
Health and Welfare (THL), 2018). 
Additionally, vaccinating is proven to be the most cost-effective health promotion invest-
ment due to its easy accessibility even to the most hard-to-reach populations at remote 
areas (WHO, 2016). In Finland the basic vaccinations, which are part of the national 
vaccination program, are voluntary and free of charge (THL, 2017a).  Therefore, the 
public’s trust in vaccine safety is of great importance in the success of vaccination pro-
grams (WHO, 2013). Overall, vaccination is a good health promotion and prevention 
action as it does not require any major lifestyle changes in one’s life (WHO, 2016). 
4.2 Immunization 
The word immunization is used to describe the process whereby a person or a population 
is provided with protection and immunity, or resistance, against an infectious disease. 
This is usually achieved by the administration of vaccines. Immunity is a biological state 
of a human body to be able to resist the disease trying to invade it by inducing the im-
munological memory against a specific disease-causing pathogen. Via vaccines, the 
body’s own immune system is stimulated to develop a long-lasting immunity towards any 
antigens from specific infections-causing pathogens. (Ministry of Health, 2018.) A vac-
cine contains typically particles called “agents” that resemble the disease-causing micro-
organism, created from weakened or killed forms of the actual microbe. As the “agent” 
is inserted to the immune system of the body, it starts to stimulate the immune system in 
recognizing and remembering it, so that it is able to later destroy any similar microorgan-
isms that may be encountered.  (WHO, 2018.) This response is similar to the long-term 
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protection that the immune system would develop normally after the recovery from a 
naturally occurring infection (WHO, 2013).  
Vaccination and immunization are of great importance and have many benefits (WHO, 
2016). Life-threatening infectious diseases cause a lot of deaths all over the world but 
due the actions taken to create immunization, estimated 2 to 3 million deaths are averted 
each year (WHO, 2019). Vaccination does not only protect the individuals but can also 
benefit a wider community. Moreover, a wide vaccination and immunization coverage, 
often referred to as the herd immunity, occurs when vaccine coverage is so high that an 
infectious disease is unlikely to encounter any susceptible contacts and transmission 
stops. Herd immunity (or community immunity) prevents infections from spreading and 
can even make them non-excitant, whereby it also benefits all the individuals who are 
not, for one reason or another, able to receive some vaccines themselves. (Ministry of 
Health, 2018.)  
In addition, vaccinations can also help to limit the spreading of antibiotic resistance as 
they reduce the need to use antibiotics in treatment of certain diseases (WHO, 2016). 
Studies have shown impacts that vaccines can have on the spreading of antibiotic re-
sistant bacteria. The main effect is that vaccines directly reduce the spreading of infec-
tious diseases and thus, naturally reduce the amount of antibiotics used in their treatment 
in the first place. (Klugman & Black, 2018, p. 12896-12897.) Vaccines also have an indi-
rect effect as they reduce the amount of specific complications that are linked to certain 
infectious diseases which often require the use of antibiotics (Ravi M., Ernesto Oviedo-
Orta, Prachi Prachi, Rino Rappuoli and Fabio Bagnoli, 2012, p.3). 
4.3 National Vaccination Program for Children in Finland 
The vaccination program in Finland has been carefully considered and developed by 
professionals to cover all the infectious disease causing-pathogens relevant to people 
living in Finland. It is recommended for each child in the country, or an adult in the older 
age, to receive the suggested vaccinations, unless presented with a disease preventing 
the vaccination. (THL, 2018, p.5.) The program covers vaccinations against eleven dis-
eases and their long-term complications. All of these vaccines are free of charge and 
available to every single young person living and residing in Finland. If a child for reason 
or another has not received the given vaccines as a young patient, they can receive the 
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vaccinations in school- or student health care. (THL, 2018) A child is considered “unvac-
cinated” if they have not received any of the Rotavirus-, PCV-, MRR- or 5-in-1 / 4-in-1 
vaccinations, meaning the DTaP-IPV-Hib / DTaP-IPV-vaccines (THL, 2019a). 
Additionally, girls are offered the Human Papilloma Virus-vaccine (HPV-vaccine) against 
cervical cancer, which is administered at the age of eleven to twelve. The HPV-vaccine 
has been offered as part of the national vaccination program since 2013.  (THL, 2018.) 
Recent suggestion made by THL in Finland promotes the idea that the HPV-vaccination 
would also be added to the vaccination program for boys, which according to studies 
would help prevent cancers caused by the HPV. Since the vaccination coverage for the 
human papilloma virus is not yet at a desired level, adding the HPV-vaccine for the vac-
cination program of boys would also improve the girl’s protection against the spreading 
of HPV. (THL, 2019b) During the spring 2020 the Finland’s Ministry of Social Affairs and 
Health made a decision to add the HPV vaccine as part of the official National Vaccina-
tion Program for boys as well as for girls. The vaccination administration is to begin ear-
liest in the autumn of 2020. (THL, 2020b.)  
Due to the well-organized vaccination program, research shows that the vaccination cov-
erage in Finland is at an excellent level. This has led to the extinction of almost all of the 
dangerous infectious diseases within the country. However, if more and more people 
refuse the vaccines, these diseases might return. (THL, 2018, p.7.) The children vac-
cination coverage is being monitored and followed with the national vaccination register, 
which is done in co-operation with the regional health centres in Finland and the National 
Institute for Health and Welfare, to better gain an understanding of how many children 
receive the vaccines every year (THL, 2019a). The National Vaccination Program for 
Children in Finland can be seen below in Table 1. In this thesis the focus will be on the 
vaccination program of children from ages 0 to 6 years old.   
 The National Vaccination Program in Finland (THL, 2020a) 
Age Vaccine Disease 
2 months  Rotavirus Rotavirus diarrhea  
3 months  Pneumococcal 
conjugate (PCV) 
Meningitis, pneumonia, sepsis and ear infection 
3 months Rotavirus Rotavirus diarrhea 
3 months  5-in-1 vaccine 
(DTaP-IPV-Hib) 
Diphtheria, tetanus, pertussis, polio and Hib diseases, 
such as meningitis, epiglottitis and sepsis  
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5 months  Pneumococcal 
conjugate (PCV) 
Meningitis, pneumonia, sepsis and ear infection  
5 months  Rotavirus  Rotavirus diarrhea  
5 months 5-in-1 vaccine 
(DTaP-IPV-Hib) 
Diphtheria, tetanus, pertussis, polio and Hib diseases, 
such as meningitis, epiglottitis and sepsis 
12 months Pneumococcal 
conjugate (PCV) 
Meningitis, pneumonia, sepsis and ear infection 
12 months 5-in-1 vaccine 
(DTaP-IPV-Hib) 
Diphtheria, tetanus, pertussis, polio and Hib dis-
eases, such as meningitis, epiglottitis and sepsis 
12–18 months MMR(MPR) Measles, mumps, rubella  
6 months –6years Influenza Seasonal influenza (annual)  
18 months Chickenpox Chickenpox (Only for children who not yet have had the 
disease)  
4years 4-in-1 vaccine 
(DTaP-IPV)  
Diphtheria, tetanus, pertussis, polio  
6years  MMR Measles, mumps rubella 
girls aged 11 to 
12years 
HPV Cervical Cancer 
14 to 15 years dtap Diphtheria, tetanus, pertussis (whooping cough) 
 
4.4 Vaccination administration competence  
All vaccines are prescription medicines, meaning that they can only be administered by 
trained health-care professionals (Ministry of Health, 2018). Often the image and idea of 
vaccinations is simply treated as no more than giving a simple injection by anyone having 
received the minimal training. In reality the whole process is more complicated and 
should be carefully planned and executed. (Nikula, 2009, p.174) According to the law in 
Finland, the only qualified vaccinators are doctors and public health nurses, nurses, mid-
wifes and nurse-paramedics, who have been given the proper training and have proven 
their knowledge and techniques. These techniques have been specified in detail by the 
National Institute for Health and Welfare (THL) in Finland. (THL, 2017a.) 
A competent vaccinator needs to be up to date on their knowledge and skills required for 
safe administration of vaccines. THL has listed eight points which include: 1. Basic 
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knowledge of the diseases prevented by vaccines, 2. Deepening knowledge of the con-
tent and administration of vaccines, 3. Knowledge of the basic safety guidelines in vac-
cinating, 4. Aseptic procedure while administering vaccinations, 5. Correct preservation 
and disposal of vaccines, 6. Complete knowledge of different vaccine administration 
techniques, 7. Correct recording of vaccinations, and 8. Knowledge of the possible ad-
verse reactions of vaccines. Ultimately, the doctor is in charge of vaccinations adminis-
tered in the department, but every single vaccinator needs to be able to prove their 
knowledge in the listed areas in order to administer vaccinations. (THL, 2017b.) It is vital 
that every vaccinator has been given the training to prepare, administer and dispose the 
vaccinations correctly because otherwise the desired effect of vaccinations will not be 
met (WHO, 2019).  
In the world today, small but highly active group of people are extremely critical of vac-
cinations. This group is gaining more and more support, and most of them refuse either 
in whole or partially to be vaccinated themselves or let their children to receive the vac-
cinations offered. The skills required for a competent person administering vaccinations 
not only include practical but social as well. Therefore, a professional who administers 
vaccinations should independently update their knowledge on the latest research about 
the topic in order to better explain the importance of vaccines to these types of groups. 
(Nikula, 2009, p. 174,177-178.) The research also showed a competent vaccinator to be 
someone with the ability to empathize with the client by remaining calm, honest and 
confident. These characteristics will provide the client with security as they are coming 
to the vaccination procedure. In addition, safety and security are achieved when a health-
care professional is able to observe and treat the clients with respect, in a professional 
manner. (Nikula, 2009, p. 178.)  
4.5 Vaccination procedure 
The whole procedure of preparing, administering, monitoring and recording of vaccina-
tions has been carefully planned and instructed through various sources. In Finland, the 
official guidelines are given by the National Institute for Health and Welfare (THL), whose 
instructions are also followed by the teaching programs of various health-care schools 
while training the future nurses, doctors and other health-care professionals. (THL, 
2017c.) 
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It is vital that the administration of vaccines is done properly to enhance the success of 
the immunisation program (CDC), 2019a).  It all starts with the preparation of the vaccine. 
Each vaccine has a unique way in which they are prepared and stored before the admin-
istration. Even before preparing the vaccine, the health-care professional should always 
make sure that there are no limitations or contraindications for the vaccination. All vac-
cinators have the responsibility to educate themselves of any new vaccines they come 
in contact with, prepare or administer. (THL, 2017a).  All vaccines administered as an 
injection should be drawn into syringes in the designated, sterile areas. Before drawing 
the vaccine, the liquid and diluent should be inspected via eyes to make sure that it has 
not been contaminated or damaged. One should not administer any vaccines that are 
suspected to be deteriorated or have expired. All vaccines drawn up to syringes should 
be used immediately or disposed properly. (CDC, 2019.b) 
Choosing the site of vaccination is the next action taken in vaccination procedure. Sev-
eral guidelines are given concerning this and each vaccinator should be familiar with 
them before administering vaccines. All vaccinations are given either via oral-, intrana-
sal-, intramuscular- or subcutaneous route. For example, the Rotavirus-vaccine (Ro-
taTeq-vaccine in Finland) is only administered orally while almost all other inactive vac-
cines are administered intramuscularly. Oral administration means, that the vaccine is 
administered as a liquid to the mouth. The vaccine is usually in a prefilled bottle, ready 
to be administered. Nasal administration is through the nose as an inhalation, for exam-
ple the influenza vaccine in Finland is administered to young babies and children in this 
matter. (THL, 2019a; CDC, 2019a.)  Needles for administering the vaccine are choses 
by the guidelines given, depending on the route of administration. Nowadays many vac-
cines come in pre-filled syringes, some of them already having needles attached as well, 
which makes it easier for the health practitioner to administer the vaccine with proper 
equipment. (THL, 2017b; CDC, 2019c.) The following guidelines are given in Finland for 
the needle-choosing while administering vaccinations (see Table 2.).  
 Choosing the size of the needle (THL, 2020a; CDC, 2019a) 
The route of vaccination Needle gauge Needle length 
Intradermal, ID  26 G 10 mm 
Subcutaneous, SC  23-25 G 16-30 mm 
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When small children and babies receive vaccines by injection, it is primarily administered 
into the thigh muscle, thought the vaccinator can use their own judgement as to where 
they give the injection. Adults and older children receive the vaccine to the deltoid muscle 
on the shoulder if possible. (THL, 2018) When given multiple vaccines at the same time, 
each of them should be ministered to separate limbs if possible. The site of vaccination 
should be clean and whole, without any rash or wounds. (THL, 2017b) Correct admin-
istration of vaccines is the responsibility of every single nurse, doctor or other health-
care professional, and the alternative injection sites or use of needles should always be 
based on professional judgement and knowledge (Ministry of Health, 2018). The National 
Institute for Health and Welfare in Finland has really clear guidelines to each injection 
technique and these are taught to all health-care students in the institutes around the 
country. The different techniques for vaccine injection are also illustrated in Figure 1.  
 
 
 Different injection techniques (Department of Vaccines and Biologicals, 2001) 
The experience of the patient, especially a paediatric one, during vaccinating correlates 
largely with the skills and knowledge of the healthcare professional. The WHO’s Strategic 
Advisory Group of Experts on Immunisation (SAGE) have given some recommendations 
to help minimize the pain and fear of the patient during the vaccination appointment. 
These include for example the advice of not aspirating the syringe when giving vaccines, 
administering the vaccines in order from the least to the most painful one and providing 
Intramuscular, IM  20-25 G 25-40 mm 
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appropriate distractions. When vaccinating infants, mothers are supposed to be encour-
aged to breastfeed or feed the baby before and during the vaccine injection. Also, the 
use of topical anaesthetics, such as EMLA, could be considered if one has remarkably 
low tolerance for pain. (Ministry of Health, 2018.)  Evidence also shows that the rubbing 
or stroking of the skin nearby the injection site before and during giving the injection, has 
an effect of possibly decreasing the pain in older children and adults. Parent’s participa-
tion during the injection has also been seen to be of help. One can encourage the parent 
or guardian to hold and comfort the child during the vaccine administration, or to create 
distraction by talking or playing with them. Parents can also prepare for the vaccinations 
with their children by reading and discussing with them about vaccinations beforehand 
at home in an honest way. (CDC, 2019a.) 
Every vaccination administering should be followed with the post-vaccination advice, 
both verbally and in a written form (Ministry of Health, 2018). The administrator should 
provide the parents and children with information of possible adverse reactions that the 
given vaccines might cause, and also guide them with the possible instructions of how 
to treat those reactions. Every patient receiving vaccinations should be monitored for 15 
minutes after the injection, in case of severe allergic- or other vaccination reactions. 
(THL, 2018.) 
4.6 Adverse reactions and preparing for them  
Centers for Disease Control and Prevention (CDC) explains different classifications re-
garding adverse reactions that follow the vaccination procedure. These reactions can be 
classified by frequency, extent, severity, causality and preventability. Thus, they can be 
determined for example as common or rare, and local or systemic. Additionally, adverse 
events can happen due to coincidence or the risk of these may be increased by the 
vaccine (CDC, 2019b.) However, adverse reactions associated with vaccines are rare 
and affect only a small sample of the vaccinated individuals. The more common symp-
toms caused by vaccination are milder and often last for only a few days. The parents of 
the children should be educated prior to vaccination, about the possible adverse events, 
to decrease their concerns and prepare them for the possible outcomes. These possible 
reactions should also be repeated to the parents after the vaccination to make sure that 
they understand and remember them. (THL, 2019a.)  
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Every vaccination administrator should also be adequately educated and trained for 
treating any possible adverse reactions.  Each vaccine has specific common adverse 
reactions and the health care worker should always get him/herself familiar with these 
prior administering the vaccine. Most common of these reactions are local and can in-
clude small irritation, redness, swelling or mild pain surrounding the injection site. Mild 
fever can also be included to these typical symptoms. (THL, 2019d.) Like any other med-
ication, also the vaccines have a possibility to cause more severe allergic reactions for 
some clients, or even anaphylaxis. The possibility for this is approximately 1 out of million 
but still the vaccinator has to be aware of its possible occurrence. For this purpose, it is 
recommended that after receiving the vaccine, all clients would stay in for at least 15 
minutes time for surveillance. In this way, the health care professional is able to quickly 
react to any possible worsening in the client’s condition. Adrenaline or EpiPen should 
always available for use in these conditions, following the given instructions in the ad-
ministering. (THL, 2019a, e.) Parents also need to be educated on the treatment of ad-
verse reactions, such as administering medication for pain or fever. It is also important 
to advice the parents to get in contact with the health care system quickly if some of more 
severe the reactions occur. (THL, 2019e.) 
5 Counselling parents of young children 
5.1 The importance of appropriate client counselling 
Public health nurses are often the administrators of vaccinations and play a vital role in 
communicating information to parents of young children (Austvoll-Dahlgren, Helseth, 
2012, p. 271). An online survey on health care providers’ and parents’ attitudes toward 
administration of new infant vaccines suggested that when parents are educated on vac-
cines and preventable diseases, they are more likely to have acceptance for those vac-
cines (Bakhache, Rodrigo, Davie, Ahuja, Sudovar, Crudup, 2012, p. 491). They also 
concluded that increasing preventable-disease awareness on a wider public scale would 
improve parents' attitudes on infant vaccination procedures globally (Bakhache et al. 
2012, p. 492). In addition, a literary review on addressing vaccination hesitancy found 
that two thirds of parents in Canada believe professional health care workers, such as 
nurses or public health nurses, the be the most reliable source when it comes to infor-
mation about immunization. Therefore, primary child health care centres provide valua-
ble patient education in terms of increasing parents' confidence in vaccinations. (Shixin 
& Vinita, 2019, p. 176.)  
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When it comes to immunization, children often have a fear of vaccinations and these 
invasive procedures can involve the experience of pain, distress and fear (Harder, Chris-
tensson, Söderbäck, 2014, p. 268).  In Finland, the vaccinations are often administered 
at the health clinic, thus providing a safe and familiar environment for both the parent 
and the child. (Nikula, 2007, p. 182.)  
5.2 The health care professional’s role in client counselling 
Nurses are in an important role as they provide knowledge to parents about the immun-
ization of their children. Therefore, it is vital that nurses keep up to date with current 
knowledge and know how to access and utilize it in a way that the parents’ concerns will 
be mediated. (Austvoll-Dahlgren, Helseth, 2012, p. 276-277.) In their review, Shixin and 
Vinita (2019, p. 177) found different strategies that could be implemented in order to 
improve parents’ vaccination confidence. Research shows that starting the counselling 
of parents early, in the beginning of the pregnancy, improves the parents’ adherence to 
the vaccination schedule. It is recommended that counselling is done both pre- and post-
natally as well as doing follow ups one month after birth. Thus, providing parents plenty 
of opportune moments to ask questions together with the provision of credible support 
material. (Shixin & Vinita, 2019, p. 177.) Another approach mentioned in the article was 
to present the required vaccinations in a presumptive way as opposed to a more partic-
ipatory manner. This type of approach resulted in a significantly higher vaccine adher-
ence rate amongst the parents who initially had concerns regarding immunization. 
(Shixin & Vinita, 2019, p. 177.)   
Previous studies have shown that there are various approaches that can be utilized in 
enhancing the child’s experience of the vaccination procedure. These involve both phys-
ical and pharmacological interventions such as sitting up instead of the child lying down 
or the use of topical local anaesthetics. (Harder, Christensson, Söderbäck, 2014, p. 268.) 
During the vaccination procedure it is vital for the health care professional to guide the 
parent and the child on the procedure at hand. Specific instructions are given on how to 
hold and comfort the child during the procedure. Additionally, information about possible 
pain management is discussed. The child often feels safer when the parents cooperate 
with the nurse and have concrete knowledge on how to proceed during vaccination. It is 
also important to discuss about the possible adverse reactions beforehand and how such 
incidents would be handled. It is also recommended that the nurse hands out written 
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instructions of the procedure. This way parents can remember better what was discussed 
regarding their child’s vaccination process. (Nikula, 2007, p. 184.) 
5.3 Encountering a child at the health clinic 
It is vital that the child’s wellbeing is at the forefront, when the family visits the child health 
clinic. Furthermore, it is important for the health care professional to give care by consid-
ering the point of view of the child, because each meeting might have an impact in the 
child’s development. Therefore, the environment should be one where the child can feel 
important, safe and supported.  It is essential to listen and encourage the child by for 
example asking them directly how they are feeling and what is important to them in their 
daily life. (STM, 2004, p.94.)  
Additionally, the nurse should show their respect toward the child by explaining to them 
directly the possible procedures and examinations. Another way to create a welcoming 
environment is by including play in the care and having toys available during the appoint-
ments. Rushing the procedures is not an efficient way when caring for a child, thus it is 
imperative to allow the child time to get familiar with the surroundings. Furthermore, it is 
important to encourage the child by complementing in an honest way that addresses the 
uniqueness and significance of the individual child. This allows the child to feel valuable. 
(STM, 2004, p.95.)  
5.4 Pain management techniques during vaccination 
The basis of administering vaccines to children is to eliminate pain associated with the 
injection. However, if it is not possible to make the procedure painless it is vital to make 
the experience of pain as small as possible. (Nikula, 2007, p.185.) Help Eliminate Pain 
in Kids (HELPinKIDS) (2015), a multidisciplinary team from Canada, offers recommen-
dations on how to alleviate the pain of a child during vaccination. These recommenda-
tions are divided into four different sections which include procedural, physical, pharma-
cological, and process interventions. Respectively, these discuss the injection tech-
niques, the positioning of the child, the use of pain medication and patient education. 
(Taddio et al., 2015, p.976-980.) Moreover, it is important to inform parents about pain 
management because parents are affected when they see their child in distress (Nikula, 
2007, p184).  
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Aspiration is not recommended when administering the vaccine. According to studies, 
there is no harm when giving the injection into the recommended muscle sites, because 
no major blood vessels are present there. With aspiration, the needle might move and 
stay longer in the tissue, which can increase pain in the injection site. Thus, creating 
increased distress to the child. Another recommendation is to inject the different vaccines 
in the order of the least painful to the most painful one. (Taddio et al., 2015, p.976.) 
HELPinKIDS (2015) also discusses the importance of proper holding and positioning 
techniques in managing pain. By incorporating these, the child can feel safer and com-
forted during the process. In older children, sitting in an upright position allows them to 
feel more in control and thus, their fear and experience of pain is decreased. (Taddio et 
al., 2015, p.978-979.)  
Furthermore, pharmacological intervention recommendations include using topical an-
aesthetics in children under 12 years old or the use of sucrose solution in children under 
2 years. According to a meta-analysis, children experienced less pain when topical an-
aesthetics were utilized. Thus, having a less distressful experience and advocating for 
children not developing a fear of needles later in life. (Taddio et al., 2015, p.979-980.)  
However, the topical anaesthetics only numb the skin and the process of applying them 
can create a distressful situation before the actual administration of the injection, which 
only lasts for a short while. (Nikula, 2007, p. 185). Pain can also be minimized using 
correctly sized needles and right injection techniques (Nikula, 2007, p.185). Finally, pa-
tient education is at the centre of any nurse patient relationship. Thus, it is especially 
important to educate parents about the pain management techniques in advance. Par-
ents can then cooperate with the nurse in using these techniques while creating a better 
vaccination experience for their child. (Taddio et al., 2015, p. 980.) When the parents 
and the nurse act calm in the situation the child will pick up on this atmosphere and feel 
calmer during the procedure.  (Nikula, 2007, p.184)  
5.5 Holding positions during vaccination  
Finding the right position for the child during vaccination is an important part of the pro-
cess and should be allowed enough time. The vaccinator instructs the parents on the 
best way to hold their child at the same time considering that parents know their own 
child the best and thus, it is important to collaborate with the parents on what holding 
method would be the most efficient. Additionally, the child’s age should be taken into 
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consideration when vaccinating. If the child can participate in the conversation it is im-
portant to include them because this will allow them to feel safer during the vaccination.  
Having an appropriate technique when holding a child during vaccination is very im-
portant for the vaccine to be successfully administered. The child might possibly try to 
struggle and pull away because they are scared. If the child is moving during the vac-
cination the needle might move inside the tissue. This can inflict pain on the child, or the 
vaccine might end up in the wrong compartment. Another risk associated with the child 
moving during vaccination is an accident involving the needle. Therefore, it is extremely 
important that the child is held properly throughout the whole procedure and they will be 
released only after the needle is safely removed from the area of injection. (Nikula, 2007, 
p.184.)  
The position of how the child should be held must be instructed carefully and in practice 
because the position can vary with every individual patient and parent. The position 
should feel comfortable and safe to them. The nurse must emphasize that the grip of the 
parent needs to be firm and they will then guide the parent on how to position their hands 
precisely. (Nikula, 2007, p.187.) Centre for Disease Control and Prevention (CDC) offers 
official recommendations on how to hold an infant or a toddler during vaccination. The 
parent is suggested to hold the child on their lap while placing the child in in a hug-like 
position and gently applying pressure for security, as well as holding the child’s free arm 
steady. The parent can then either anchor the child’s feet by holding them between the 
parent’s thighs or by holding them down with their other hand (CDC, 2019d.) See Figures 
3 and 4 for guidelines on appropriate child holding position during vaccination.  
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 Positioning a child <12 months of age in the cuddle position (Australian Immunisation 
Handbook 2018). 
 
 Holding an older child in the cuddle position (Australian Immunisation Handbook 2018). 
 
Comforting the child and the parent is also an important part of the vaccination proce-
dure. The child will often experience pain from the administration of the injection and 
after the administration at the injection site. Therefore, it is natural that the child might 
hesitate and cry during the procedure. (Nikula, 2007, p. 184.) It is important to 
acknowledge the child’s pain and comfort them without adding too much emphasis on 
the pain they are experiencing. Parents might need comforting as well since seeing their 
child in pain can make the parents uncomfortable (CDC, 2019d). 
5.6 Public health nurses’ views and experiences on vaccination procedure 
According to the opinion of public health nurses, there are many important aspects to 
consider when vaccinating children. Firstly, it is important that vaccinations and the 
schedule is discussed with the parents well in advance. The conversation must be open, 
and parents should be able to ask anything regarding this topic. It is important to discuss 
these matters regularly to instil trust in the parents and to create a cooperative environ-
ment. Secondly, it is essential that the nurse creates trust and communication with the 
child. The nurse must have skills in motivating the child, especially when they are older 
and more difficult to convince to be vaccinated. In that case it is also important that the 
nurse is honest with the child and lets them know that even though it hurts there will not 
be any harm to them. Finally, the vaccination procedure must be safe for both the child 
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and the nurse, as well as the parents. Therefore, it is vital that there is trust and cooper-
ation and right holding and vaccination technique. Additionally, there are some tricks that 
the vaccinator can benefit from using while vaccinating. These include giving the vaccine 
first which is less irritating to the child when multiple vaccines are given during one ap-
pointment. The nurse can relax the patient and parents by creating a warm and safe 
environment, thus reducing the fear the child is experiencing. Children often enjoy an 
incentive, such as a sticker, given to them at the end of the procedure. Also, appraisal is 
important at the end of the visit. All these techniques will leave the child with a more 
positive experience of the vaccination procedure. (Nikula, 2007, p.191.)  
6 The Educational Video 
6.1 Definition and planning of an educational video 
Educational videos have become an important part of education at schools, especially in 
higher education. Continuous research is still being conducted but it has already been 
proven that the use of videos in teaching certain topics or subjects has a greater impact 
to the students than them just reading books or articles about the subject matter. Studies 
have shown that videos can truly be a highly effective educational tool.  (Brame, 2016 p. 
1.)  
In order for a video to become an educational video it needs to have some key features 
according to multiple different studies. Cynthia J. Brame, in the literature review found 
that some of the key recommendations for a “good educational video” are the following: 
Keep videos brief and targeted to a certain learning goal, use audio-visual elements and 
highlight and signal the important ideas and concepts, and use interactive questions in 
order to keep the learning active. (Brame, 2016, p. 6.) A checklist presented in an edu-
cational magazine also adds that the educational videos should be carefully planned, 
well structured, understandable to the target group, selected design methods should 
support the content, and the visual and audio channels should be used optimally. (Edu-
cational Development and Technology, 2015.) Both studies also suggest that an optimal 
educational video should not exceed 6-9 minutes. Another study presented statistics ac-
cording to which a video with the length of 6 minutes or less, had a viewing engagement 
close to 100%, meaning that the students would be watching almost the whole video. 
With the length of 9-12 minutes, the viewing rate would immediately drop close to 50%, 
following with the fact discovered that the average viewing time of videos with any length 
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was about 6 minutes. (Guo, 2014, p.45.) According to this, Brame (2016) success that 
an educational video should not be longer than 9 minutes. (p.4).   
Another interesting fact commented on a thesis article written by Ilkka Sartjärvi was that 
the material and content presented in the educational video does not really matter, if the 
video itself is not able to keep up the interest of the viewer. The sounds, division, move-
ments and colours in the video should be planned so that they keep up the interest and 
the attention of the student. (Sartjärvi, 2014, p. 32.) What was also pointed out was that 
the clinical actions taking place on the video, should be shown in sections, this way 
keeping up the interest and not being too long or tiring to the viewer (Sartjärvi, 2014, 
p.33).  
6.2 Our plan for the video 
A preliminary plan was made for an educational video to be created as part of this thesis, 
after conducting research about the topic and discussing with our supervisor about what 
the EDUVAC project wants. The educational video will be featuring a student, acting as 
the public health nurse, and two parents and their child. The scene of the video is that 
the parents come to the nurses’ office for their scheduled appointment in order to receive 
the next vaccinations according the schedule, and to discuss further about the upcoming 
vaccinations in the national vaccination program. The MMR vaccine will be in the centre 
of this video. The video is planned to be 6-9 minutes long, specifically focusing on the 
guidance given to parents regarding vaccinations and the vaccination procedure. Filming 
will be done at an actual health care centre if possible. Another option for the filming 
location is the clinical laboratory space at the new Metropolia campus in Myllypuro. Ad-
ditional help will be gathered from the digital-field teachers. The video will be filmed with 
the filming equipment available at school.  
6.3 Background information for the video 
The counselling video was planned take place at a Health Care Centre, where parents 
come to with their 1-year old child to receive the MMR vaccine as part of the national 
vaccination program in Finland. MMR is administered for the first time at the age of 12 
months. For producing an effective educational video, the following background infor-
mation was researched.  
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6.3.1 Administering an intramuscular vaccine  
All vaccines given by injection should be administered on a site where any neural, vas-
cular or local tissue damage or injury is unlikely. Considering the patients age and size, 
the intramuscular injections are generally given to the anterolateral aspect of the thigh 
muscle or the upper arm deltoid muscle. These sites are illustrated in the picture below 
(see Figure 4.) (CDC, 2019c.) With contrast to the old protocol, the use of gluteal area 
when vaccinating is no longer recommended. In the tight muscle area for example there 
are far less nerves or veins that could be damaged than on the gluteal muscle area. Also, 
the vaccines are faster to absorb from the thigh or deltoid muscle than from the gluteal 
muscle which is commonly surrounded with more subcutaneous tissue. (THL, 2017b.)  
The needle size needs to be considered and decided according to the injection site, and 
the size and body mass of the patient. When administering the intramuscular injections, 
meaning the injection given to a muscle, it is important that the needle is long enough to 
reach through the subcutaneous tissue to the actual muscle mass. However, it is im-
portant to make sure that all possible underlying nerves, blood vessels and bones are 
left unharmed during vaccination. (CDC, 2019c.) 
The size of the needle should be between 20-25G, and the most common needle size 
used for vaccination is 23G. Many of the vaccines come in a pre-filled syringe in which 
case the health care professional might not have to choose the correct needle. When 
vaccinating a paediatric patient however, it is important to change to a smaller needle or 
only partially insert the needle into the tissue. (THL, 2017b.)   
 
 
 Intramuscular injection sites for a pediatric patient (CDC,2019c) 
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When administering vaccines to a paediatric patient, the site of vaccine injections de-
pends greatly on the age and size of the child. Recommendations are that to children 
younger than 12 months, the intramuscular injections should be generally given to the 
thigh muscle, meaning the vastus lateralis, which is the upper-outer part of the thigh. To 
children from ages 1 to 6, the vaccine can be administered either to the deltoid or the 
thigh muscle. When administering the vaccine, first make sure the vaccine is prepared 
properly and is ready to be used. Ask the parent, if present, to hold their child and espe-
cially the vaccinated leg with a firm grip so that the they will stay put. Hold the leg with 
your own hand tightly as well. This helps to administer the vaccine securely to the muscle 
tissue. (THL, 2019f.)  
The skin area is not required to be cleansed but if so, the antiseptic used should be 
allowed to dry completely. The vaccinator takes a firm grip of the muscle, while at the 
same time inserting the needle into the muscle in a 60-90-degree angle to the skin, most 
often in 90-degrees. Once the needle is in, the needle is supported with the other hand 
to make sure it stays in place and makes sure that the needle is not in a blood vessel by 
pulling back the stem a little bit to check if there is blood coming to the syringe. Although, 
aspiration is not necessary. After this the vaccine is slowly inserted into the muscle. The 
needle is then removed from the tissue and the injection site is pressed for a couple of 
seconds with a clean pad. (CDC, 2019c.) After the injection it is important to inform the 
parents of the possible local reactions that might occur on the injection site. When ad-
ministering the vaccine into the thigh muscle it is common that there might be some local 
pain and for example the child might refuse to walk or put weight on the vaccinated leg. 
This is totally common but does not occur with every child. Normal pain medication can 
be used to treat this symptom and it usually fades away within just a few days. (THL, 
2019f.)  
6.3.2 The MMR Vaccine 
The MMR vaccine is an effective and the only way to protect oneself against measles, 
mumps and rubella which are highly infectious diseases. Most people vaccinated with 
the MMR vaccine have a protection for a lifetime according to most recent studies. In the 
future there might be a third vaccine recommended but for now the two-phased program 
is used. (THL, 2019g; THL 2020c.) Despite the vaccine, people might still be at risk of 
getting the diseases, but the symptoms are really mild and often the exposure time to 
the pathogen has to be really long and close. Vaccinated people are also creating pro-
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tections for those who are not able to receive the vaccine themselves. This group in-
cludes for example people who have had a serious, life-threatening allergic reaction from 
the vaccine, are pregnant or have a weakened immune system due to an illness.  (CDC, 
2019e.) Every child and adult should have immunization against the three diseases ei-
ther by vaccination or by having gone through the diseases. In Finland, the MMR vaccine 
is given as part of the national vaccination program at childhood, but it can also be ad-
ministered later on if the person for a reason or another does not have an adequate 
defence for the diseases. It is also advised to give the vaccine to a person who has an 
unclear record for the immunization even when they might have received it already. 
(THL, 2020d.) 
The measles vaccine was first administered in Finland in 1975 when the vaccine was 
given to a 1-year-old child as a one-time vaccine. The combined MRR vaccine, which 
includes pathogens for measles, mumps and rubella, has been used since 1982 in the 
two-phased vaccination program and because of that, measles, mumps and rubella have 
all almost completely disappeared from the county. (THL, 2019h.) Thus, the sequela 
diseases such as meningitis, testicular infections and pneumonia requiring intensive hos-
pital care have also been tamed down. The vaccine is administered with the schedule of 
two dosages. The first dose is given to a 12 to 18-month-old child, preferably right at the 
age of 12 months. However, the MMR vaccine can be administered as early as the age 
of 9 months. This is strongly recommended if the family, for example, is travelling some-
where outside of Nordic countries or Estonia. (THL,2020c.) The second dosage is ad-
ministered at the age of 6 and is given as a booster for the first vaccine. If a child has not 
yet had chicken pox by the age of 6, they receive the MMRV vaccine which also includes 
protection against it. (THL,2018.)  
The two brands of MMR vaccines in Finland are the PRORIX and the M-M-RVAXPRO- 
vaccine. The PRIORIX is administered either intramuscularly or subcutaneously but the 
M-M-RVAXPRO is recommended to be given only intramuscularly, since it can cause 
pain and irritation if given to the subcutaneous tissue. (THL, 2020c.) Both of the vaccines 
include living pathogen viruses of measles, mumps and rubella that have been weak-
ened. These pathogens cannot cause the vaccinated individual to get the diseases but 
instead will develop an immunisation against them. The vaccines are only to be admin-
istered and prepared by a health-care professional who has been given and adequate 
training regarding vaccination. Both of the vaccines come in a package that includes an 
injection bottle with dry powder and a pre-filled syringe with a clear liquid solvent. The 
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solvent is injected into the bottle and the vaccine is lightly shaken until the powder has 
completely dissolved. Depending on the vaccine used, the ready vaccine is either peach 
to fuchsia colour (PRIORIX) or lightly yellowish colour (M-M-RVAXPRO). The prepared 
vaccine is then drawn back into the syringe and should be either administered right away 
or stored in the fridge and used within 8 hours from the preparation. The product should 
never be allowed to freeze. (Lääketietokeskus, 2019.)  
Just like any vaccinations or medications, these vaccines have some adverse reactions 
which occur in different ratios. Most common reactions, occurring with more that 1 out of 
10 people, are redness around the injection site and a mild fever. There can also be 
swelling and some pain at the site of the injection, and some people might develop a 
rash or upper airway infection. However, these occur within less than 1 out of 10 people. 
Rare but possible adverse reactions include middle ear infection, insomnia, redness and 
irritation of the eyes (conjunctivitis’s) diarrhoea, vomiting, hives or aseptic meningitis. 
Some cases of seizures, joint pain and severe allergic reactions have been reported but 
these affect less than 1/100 of the vaccinated. (Lääketietokeskus, 2019.) The post vac-
cine symptoms usually appear 5-12 days after the vaccination and last from a couple of 
days to a week. The common disease-like symptoms after receiving the vaccine are not 
a contraindication for the second vaccine. Usually the symptoms or reactions only occur 
after the first MRR vaccination. Some people might not receive any symptoms after the 
vaccination. (THL, 2019g.)  
6.3.3 MMR vaccination coverage  
Since the MMR vaccine was started to administer in Finland in 1992, the main source of 
measles and rubella infections have been from countries abroad. However, in the recent 
years there have been some reported cases, where people have been diagnosed with 
measles and got infected in Finland. (THL, 2019h.)  
In a study conducted by the ECDC (the European Center for Disease Prevention and 
Control), there were 17 measles cases and 0 rubella cases diagnosed and reported in 
Finland. According to THL there were also 4 mumps cases diagnosed in the year 2018. 
The highest numbers of cases reported where in France, Romania, Italy, Poland and 
Bulgaria. (ECDC, 2020; THL, 2019h.)  Also, there have been great outbreaks in countries 
outside of Europe, for example in Brazil, Samoa, Philippines, Thailand and New Zealand. 
The biggest Rubella outbreaks have been recorded in South-Africa, India, China, Poland 
and Germany. All the recent measles-, mumps- and rubella outbreaks in European- and 
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other countries are clearly been occurring due the low vaccination coverage among the 
citizens in those countries. In Finland the coverage is still relatively good, being over 90% 
and WHO has officially cleared Finland as a measles-free country. However, the cover-
age for Finland does not add up to the WHO´s recommended safe herd coverage for 
measles which should be over 95%. (Kontio M., 2020.) The vaccination coverage for 
Europe is illustrated in Figure 5. 
 
 
 Vaccination Coverage of the measles and rubella in Europe, (ECDC, 2019) 
One large concern people have about the MMR vaccine has been due to a study was 
study which suggested a link between the vaccine and autism. This caused a lot of hes-
itation in parents and still creates concern among some groups of parents regarding 
vaccinating their child. The study was first published in 1998 and since then there have 
been many studies proving the link wrong. Yet some people choose to believe the study 
and hence, it is still causing challenges. Recently there was a nationwide cohort study 
made, which has clearly proven that there is no relation between the MMR vaccine and 
autism. The study simply states that no support for the hypothesised link between the 
MMR vaccine and development of autism was found. The study was conducted as a 
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nationwide unselected population study amongst Danish children and they concluded 
that the MMR vaccine does no trigger or increase the risk of a child developing autism. 
(Hviid A, Hansen JV, Frisch M, et al., 2019.) 
6.3.4 Measles, Mumps and Rubella 
Measles is characterized as a highly contagious virus by the CDC (2019f). The virus lives 
in the infected person inside their nose and throat. It is transmitted by humans via cough-
ing and sneezing and it can stay alive in that airspace for up to two hours. Thereafter, 
the other people in that space can get infected if they touch any contaminated surfaces 
or breather the air, and then touch their eyes, noses, or mouths. (CDC, 2019g) 
 
 Measles rash (CDC 2019h)  
Because of its highly contagious status, 90% of the other people in their close circles will 
acquire the infection as well. The contagious period of the Measles is four days before 
the symptoms and in the first four days after the rash symptoms appear. Measles is more 
than a mild rash; it can be a dangerous disease especially if babies or young children 
become infected. Symptoms usually appear seven to fourteen days from the infection. 
The first typical symptoms include high fever, cough, runny nose and red watery eyes. 
After the first few days tiny white Koplik spots may appear in the mouth of the infected. 
The measles rash breaks out in the third to fifth day after the symptoms have started. 
Flat red spots first appear in the face and hairline where it descends to the neck, arms, 
legs and feet. Additionally, some raised bumps can appear with the red spots and the 
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spots can join together when they spread to the whole body. At the time of the rash the 
patient’s fever can also spike to above 40 degrees Celsius. (CDC, 2019f.) 
Mumps was a common viral infection in children before the MMR vaccine (NHS, 2018). 
This disease is characterized by the puffy cheeks and a tender swollen jaw also called 
parotitis. This occurs due to the swollen salivary glands which can be found on both sides 
under the ears. Mumps is contagious and transmitted through droplets from coughing, 
sneezing or talking. It can also spread via objects that are infected with droplets. Trans-
mission happens from two days prior the swelling of the salivary glands to five days after 
this started. Some symptoms may begin before parotitis and they include fever, head-
ache, muscle aches, tiredness and loss of appetite. Usually the symptoms begin sixteen 
to eighteen days after the person has been infected but it can range from twelve days to 
twenty-five days. In some cases, the initial symptoms of Mumps are so mild that the 
person might have no idea of the disease and think of it as just a common cold. Addi-
tionally, in rare cases this disease can cause more severe complications. (CDC, 2019i.) 
These can include either an infection of the brain or temporary hear loss (NHS, 2018). 
Rubella is a virus that causes a contagious disease and it usually appears with mild 
symptoms in children. Usually about 25-50% of the infected cases show no symptoms. 
However, a red rash is usually the first sign, if symptoms appear. Rubella is transmitted 
through coughing and sneezing as droplets, and it can also be transmitted from mother 
to a child during pregnancy. The transmission period starts a week before the rash symp-
toms and continues in the following week from that. In the beginning, the rash often ap-
pears on the face and descends to the rest of the body. This lasts for about three days 
only. Additionally, there are symptoms that can appear prior to the rash, usually one to 
five days before. These may include a low-grade fever, headache, general discomfort, 
swollen lymph nodes, cough, or a runny nose. A case of mild pink eye may also be seen. 
Most of the infected adults also experience mild version of the disease with a low-grade 
fever, headache, sore throat and rash. People who are infected with rubella must inform 
others, especially women who are pregnant, of their disease. (CDC, 2017.) 
6.4 Synopsis of the video 
The parents come into the public health clinic with their 12-month-old child to receive the 
scheduled immunisation. The nurse will explain in detail what the vaccination is for and 
what adverse reactions might be associated with this vaccine to address the parents’ 
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concerns. The vaccination in question for this video is the MMR vaccine. The nurse will 
also address concerns of pain and how the parents may be of assistance during the 
procedure. The nurse will then administer the vaccination. At the end of the appointment 
the nurse will mention the upcoming vaccines. The whole script for the video can be seen 
in Appendix 1.  
7 Thesis Process 
7.1 Beginning of the thesis process 
The thesis process began with the application in the spring of 2019. An application form 
was filled, and a short motivational letter was written in order to describe our interest in 
this specific topic and project. When topics were selected by teachers an internet-based 
meeting was held on the 8th of May 2019 to further expand and discuss the specific 
topics of each group of students. Information was given regarding the expectations of 
supervisors on each topic. Specific plans were expected to be prepared during the sum-
mer of 2019. 
The first face-to-face meeting between students and supervisors was held on 13th of 
August 2019 at the Metropolia Vanha-Viertotie Campus where every topic was further 
discussed and specific goals for each Thesis was set. We started planning on what re-
search needed to be done to create an educational video about vaccinations and guid-
ance. We discussed with our teacher about the expectations of the EDUVAC-project 
concerning the video. We began researching for information regarding immunisation and 
vaccination guidelines and patient counselling. We chose the specific topic for our video: 
a client-counselling situation where parents come to their child’s scheduled appointment 
with to receive the scheduled vaccinations. We attended a workshop held by Metropolia 
Library staff regarding research techniques and guidelines and continued on searching 
for reliable references and studies to support our thesis. Search for material was made 
using the Cinahl and PubMed databases and also Google Scholar for researches on 
different topics. Also, WHO’s and THL’s websites, and also other sources, were of great 
help when researching vaccination guidelines and information regarding different vac-
cines and vaccination programs of different countries, especially Finland’s.  
We met with our supervisor before the planning-seminar on the 24th of September 2019 
to receive comments and further guidance to the current plan of our thesis. Some 
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changes were made and the plan for the educational video got more detailed. We also 
received a confidential research plan regarding the EDUVAC-project, which helped us 
to describe it more in detail in our thesis. Planning-seminar was held on 16th of October 
at Metropolia campus, where the first peer evaluation by other students was performed 
and we received constructive comments from other students and the supervising 
teacher. Further research continued and we set a deadline for ourselves to have most of 
the background information searched and written before the beginning of winter-holiday 
from school. Research was also done regarding criteria of a good educational video and 
planning a script and filming the video.  
 Thesis process schedule in 2019 
 
7.2 Implementation and completion of thesis 
The second phase of the thesis process began in the Spring of 2020. The writing of 
additional background information continued and detailed plans, for the educational 
video, were created in co-operation with the supervising teacher. More research was 
conducted regarding a quality educational video. Our plans for the video evolved during 
the spring. The initial rotavirus-vaccine for the video, was changed into the MMR vaccine. 
This vaccine is administered as a subcutaneous or intramuscular injection and has also 
• Thesis application process
• Choosing a topic for the thesis 
• Attending an online info for students beginning their thesis 
work after receiving the topic
• Doing initial research on the topic and coming up with a 
more specific idea for the thesis
Spring and summer 2019
• Narrowing down the key points of research 
• Narrowing down the thesis topic and video topic
• Attending workshops
• Meetings with our supervisor
• Writing backroung information for the thesis
• Planning-seminar (October)
• First peer-review
Autumn 2019
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been greatly discussed lately as much of hesitation has been surrounding it among par-
ents in some parts of Finland. Due to these changes, more specific information was col-
lected regarding the MRR vaccine and its administration. The video was planned to be 
filmed at a health clinic but due to the time-limitations and difficulties with licences we 
decided to film it at the Myllypuro Campus of Metropolia UAS. The family participating in 
the video are friends of ours. One of us was set to be acting as the public health nurse 
and the other in charge of the filming. 
A reporting-seminar was held at the school on the 5th of February where we introduced 
our thesis topic again and told other students about our specific plans for the video. We 
received good feedback on the thesis and on the draft of the script for the video. On the 
same day we also attended a digital workshop where we discussed with the teacher 
about our plans for the video and agreed on filming the video with the schools iPad and 
editing the video using iMovie. On the 11th of February we attended another workshop 
where we practiced filming with the iPads and created solutions for recording the sounds 
in a way that it would be clearer and easier for the viewer to hear and understand. Addi-
tionally, we practiced using iMovie to edit these practice-clips to see how editing works 
on it. During this whole process we met as a thesis pair almost once a week to discuss 
our progress and work on the thesis. A lot of individual work also went into our thesis. 
Work was divided evenly for both participants and we made steady progress. The final 
script was sent to the supervising teacher and final changes were made. Also, plagiarism 
checks were performed via Turnitin program. 
The filming was set to happen on week 12. The healthcare staff was contacted regarding 
the use of their office place and also the digital media teacher was contacted on the use 
of the iPad on a specific date. The script was finalised and sent to the family couple 
weeks before the set date for filming.  
Due to the special conditions and circumstances with the COVID-19 pandemic, special 
arrangements needed to be made for the implementation of this thesis. The Metropolia 
UAS campuses were all closed starting on 18th of March, which was originally planned 
as the filming day, and due the closure we lacked access to both classes and the filming 
equipment for an unknown period of time. Additionally, the health clinics were not able 
to lend their workspaces. Consultation was done with the lawyer of Metropolia UAS and 
no special permission could have been granted for the production of the educational 
video. Therefore, the original plan of the educational video was changed into a series of 
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photographs showcasing a client counselling situation. These photographs were to be 
taken with the students’ own equipment and the filming to be done at one of their homes.  
We gathered together with the participating family, to take photos at their own home on 
25th of March 2020. The scenario showcases a situation where the nurse visits the client 
at home and administers the vaccines there. Agreements were signed by the participants 
regarding the photoshoot. Therefore, they agreed that the taken photos can be used as 
part of the international web based intensive course by the EDUVAC-project. After this 
the photographs were edited and added as part of the PowerPoint slides, accompanied 
by explanatory text regarding each phase of the vaccination and counselling procedure. 
Attempts were made to follow the original script as closely as possible, but due to the 
circumstances and the resources available, some adjustments were made. The Power-
Point was created using an EDUVAC PowerPoint base. This PowerPoint was returned 
to the supervising teacher for approval and evaluation.  
Reporting seminar for the thesis was held online on the 7th of April. Before this date, a 
final draft of the thesis was returned to the teacher and also to the students performing 
peer evaluation. Final adjustment successions will be considered, and the last changes 
are made. The final return date for the thesis and the planned PowerPoint presentation 
is on the 17th of April.  
 Thesis process schedule in 2020 
 
• More background research on the topic
• Implementation of the thesis seminar
• Creating a script for the video
• Meeting and corresponding with our supervisor 
• Changing plans because of the COVID-19 pandemic
• Photoshoot for educational material
• Final thesis seminar 
• Returning the thesis and the final product
Spring 2020
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8 Discussion 
We feel that our thesis process was well planned, and went according to schedule and 
thus, progressed successfully overall. Moreover, we carried out communication well with 
our supervisor, teachers and each other throughout the whole process. However, be-
cause of the ongoing COVID-19 pandemic, we were unable to create the final product. 
Because of these circumstances we could not film the educational video and had to 
change our plans to a PowerPoint presentation with similar aims. Therefore, taking the 
current worldwide situation into consideration, we feel that we succeeded in creating a 
cohesive and educational presentation about our topic which can be utilized by the EDU-
VAC-project.   
8.1 Review of the product 
Our aim was to create a quality educational video for the web-based course created by 
the EDUVAC project. Unfortunately, this was not possible because of the current circum-
stances. Therefore, we will review our altered final product, the PowerPoint presentation. 
We were able to use the evidence-based information, which we gathered during our the-
sis process, to create this presentation. The photos we took for the purpose of this Pow-
erPoint turned out well, even though the home setting was not something we originally 
planned. We feel that the slides showcase well how this sort of counselling situation 
should be carried out. The purpose of this thesis was to enhance the health care stu-
dents’ competence as vaccinators. Thus, taking the circumstances into consideration, 
we were successful in what we set out to do.  
8.2 Reliability, validity and ethics 
Our functional thesis did not include actual research, instead it was completed based on 
information gathering from reliable sources and previously done studies about the topic 
without plagiarising. The final product of our thesis is an educational PowerPoint presen-
tation for a web-based course. We did not have much previous knowledge and skill in 
creating educational material, which may have affected our process. However, we re-
searched and consulted teachers in these areas to the best of our abilities.  
Ethical principles include few important aspects, beneficence and non-maleficence. Re-
spectively, these mean that the intentions should be good and should cause no harm to 
participants. (Laerd Dissertation, 2012.) This thesis has a good purpose of educating 
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health care students on an important international health promotion issue, thus being 
ethically moral. Furthermore, the participants were treated with respect and ethical prin-
ciples. Ethical principles include minimising the risk of harm, attaining informed consent, 
providing the right to withdraw and protecting anonymity (Laerd Dissertation, 2012). 
 Therefore, before we carried out the photoshoot, we made sure on multiple occasions 
that our participants still wished to be part of the filming. We informed them of the 
changes to our plans and made sure they agreed with the changes. It was also important 
for them to know this was completely voluntary and they could withdraw at any moment 
if they wished to do so. We explained what the aims of the photos we took were and that 
they were going to be part of an educational web-based course for the EDUVAC project. 
During the photoshoot we made sure that the participants were comfortable in the situa-
tion. We worked around the child’s schedule. For example, when he got tired of the pho-
toshoot, we allowed him to take his scheduled nap and nutrition. We also made sure 
from the mom that her and her child were feeling comfortable at all times. Additionally, 
we obtained informed consent from the people participating in the photoshoot. We had 
written photo release agreements for them to sign, which were also signed by the 
Metropolia representative. The participants agreed to have their personal information 
(name) to be included in the final product.  
8.3 Usefulness of the product and suggestions for future projects 
As mentioned previously, major changes and adjustments were made to the original plan 
of creating an educational video to be used as part of the vaccination competence web-
based course. Therefore, the final product became a PowerPoint presentation, including 
photographs taken of a counselling situation between a nurse, mother and child. Be-
cause of these pictures, the PowerPoint works as learning material that can be of great 
benefit to all future students getting access to it.  
For improvement suggestions in the future, it would be more efficient if there were stu-
dents from the media-field of studies involved in these types of thesis projects. As a 
nursing student, we had little or no experience in planning, filming or editing a video and 
had to completely rely on teachers and resources found online. Additionally, due to the 
circumstances no proper equipment for filming could be borrowed from the school and 
thus, the pictures taken with a phone camera are not of the best quality. The PowerPoint 
presentation does include the same topics and key principles as the video was supposed 
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to, but we do acknowledge that the educational video would be a more efficient way for 
learning. These are aspects that could be taken into consideration when planning future 
thesis’.  
8.4 Professional growth as a nursing student  
As nursing students and health care professionals in the future we have gained a great 
amount of new knowledge about immunisation, counselling, making of educational vid-
eos and PowerPoint presentation, and the thesis process overall.  We feel that immun-
isation is an important health promotion technique worldwide and thus, we are excited to 
have learned a great deal about it. Especially, because we are conducting our nursing 
studies in English. We have learned and enhanced our skills in information gathering, 
communicating, planning scripts, filming and creating educational material. Also due the 
change of plans on a short notice, we learned about creating alternative solutions and 
also how to develop and create a good and clear PowerPoint presentation for educa-
tional purposes. We learned how educational materials are developed in practice. For 
example, we have learned what goes into it legally such as the informed consent forms.  
We believe this whole process has supported our learning immensely as nursing stu-
dents and future professionals. Furthermore, we learned time management skills on a 
wider project that stretched out for a period of a whole year. It was vital to keep to our 
schedule and co-operate with our supervisors and teachers on that timeline so that the 
thesis would keep progressing sufficiently. We also learned to adapt to changes and feel 
that this helped us to be creative in the ways we conducted this project. Overall, it has 
been a very educational part of our nursing studies.  
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Appendix 1  Script for the educational video 
Scene 1 – Encountering the parent and the child 
The health care worker (HCW) is at their office. They are preparing for the next client 
and checks for client and vaccination history.  
 
Scene 2 – Informing and parents about their child’s vaccinations 
The HCW invites the child and the parent in. They discuss about recent events and well-
being as a family.  
 HCW: Hello, how is everything going? (introduction is required if the patient 
is new) Hello ‘baby’ (make contact with the child) 
 Parents: Hi, everything is well. He has been ill a couple of times since we 
last saw you but now everything is good. He is taking his first steps and sleeping quite 
well now.  
 HCW: That’s good to hear. You have grown a lot (to the child). Do you have 
his health record booklet with you? 
 Parent: Yes, here it is, he has gotten all the vaccines on the schedule so 
far. 
 HCW: Yes, great they are all recorded here. So today we are planning on 
giving him the MRR vaccine as well as third vaccine for the 5-in-1 and the PCV vaccine 
which he has received earlier. What do you know about the MMR vaccine? Do you have 
any question? 
 Parent: Isn’t that the vaccine for measles?   
 HCW: Yes, that’s correct, and it also contains immunization for mumps and 
rubella as well.  
Parent: Ah yes! We have been reading about measles and vaccine in the news and 
social media. We are somewhat concerned about other people who are not vaccinated. 
What’s the current situation with measles here?  
 HCW: Those are good questions. Currently the vaccination coverage for 
measles in Finland is very good, there are some small areas in Ostrobothnia that have 
a lower coverage but nothing to be worried about yet. But there are areas in the world, 
even in Europe where the situation is worse and in case of travelling, it is good that he 
has sufficient coverage. It’s very good that you are vaccinating him, because there is 
hardly any chance, he will get ill. And even if he does there would have to be a strong 
exposure, and the symptoms will be milder and there will be no complications afterwards.  
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 Patient: Ok good to know. What possible adverse reactions are there with 
the vaccine?  
 HCW: Have noticed any reactions on him from the previous vaccinations? 
Parent: He has been a little bit fuzzy after wards in the following day but no fever.  
 HCW: That’s good. Much like the other vaccines 5-15% experience mild 
disease like symptoms. Local reactions such as pain, redness, bruising, mild swelling, 
itching, warmth in the area and mild rash can appear in within a week from the vaccine. 
They should disappear within a few days or a week. These can be accompanied with 
fever as well. These are nothing worried about and it is possible to treat the symptoms 
with appropriate fever and pain medication. You should contact the doctor if his fever 
rises higher that 40 even with medication or if lasts for more than three days. Also, if 
there are any seizures or paleness, or if he is very lethargic. However, these reactions 
are extremely rare. 
 Parents: Yes, thank you.  
 
Scene 3 – Holding a child during the vaccination 
 HCW: This vaccine will be given into the thigh muscle and so as you know 
it’s important that he stays still during the vaccination. You can help me by holding him 
in your arms.  
 Parent: Ok, what would be the best way to hold him?  
HCW: There are different ways of holding him, but you know him best so 
together we can find the most comfortable position. Then you will be able to comfort him 
during the vaccination because it’s normal for him to feel uneasy. We will try to make it 
as painless as possible for him.  
 Parent: Yes, I think he will be comfortable like this 
 HCW: Good, now it’s important that his legs don’t move so you can hold 
them in between your own legs and use your other hand as well. And then you can hug 
him with your other arm like you are doing right now. (guidance) 
 
Scene 4 – Instructions on how to prepare the vaccine 
 HCW: I will now prepare the vaccination 
(Package contains prefilled syringe and injection bottle.)  
 1. Insert the liquid from the syringe with a needle into the injection bottle. 
 2. Gently shake the bottle until the powder has dissolved into the liquid and 
the suspension is turbid and of light color.  
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 3. Immediately after the suspension is ready, draw it into a new syringe and 
shake the syringe gently.  
 4. Check the content of the syringe and shake rapidly if a gel like phase is 
still visible.  
 5. Swap in a clean needle and administer right away.  
 
Scene 5 – Administering the vaccine 
 HCW: I will now administer the vaccine, please hold him firmly. (To the child 
in a calming voice) This will pinch a little, but everything is ok.  
1. The vaccinator prepares the area by exposing the surface (cleansing is not nec-
essary according to guideline but if done, the area needs to be let dry com-
pletely before administering any injections) 
2. Health care worker takes a firm grip and injects the needle into the muscle in a 
90-degree angle 
3. Once the needle is in, the vaccinator supports it with her other hand while aspi-
rating slightly to see there is no blood. (Aspirating is not necessary, but it can be 
done) 
4. Then the vaccine is slowly inserted into the muscle  
5. The vaccinator takes the needle out and firmly presses the area 
6. Appraise the child for the procedure  
 
Scene 6 – Summary/follow up instructions  
 HCW: Alright that went well, you were very brave! The holding worked well! 
(comfort child and parent)  
 Parent: It went well, it’s over now (Talks to the baby)  
 HCW: Let’s mark this on his vaccination card and here you can see that 
the next vaccination is at the age of 4 and it’s a part of the basic series following for what 
we gave him now. Also, possible other vaccinations before that can include the influenza 
vaccine. Do you have any questions?  
 Parent: Not right now. Thank you for today! 
 HCW: Thank you for coming in and being so brave! Here’s also some in-
formation for you to take home with.  
 Parent:  Thank you so much. Have a great day! 
End of the video
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1
COUNSELLING PARENTS ABOUT 
THEIR CHILD’S VACCINATIONS
(ages 0 through 6)
1
This presentation provides information on how to counsel parents 
about their child’s vaccination. The following slides showcase a 
healthcare visit where the public health nurse visits the clients’ home. 
During the visit their one-year old child receives vaccines according to 
the vaccination schedule. The MMR-vaccine is used as an example in 
this scenario. 
Encountering 
the Child  
Counselling the 
Parents  
Correct 
Holding 
Positions 
Vaccine 
Administration
Ending the 
Visit
The presentation is divided into sections that describe the different phases of an authentic healthcare visit.
2
Encountering the Child
What to consider when meeting the child and parents for the first time.
3
Encountering the Child
• It is vital that the child’s wellbeing is 
at the forefront 
• Create an environment where the 
child can feel important, safe and 
supported.
• Use toys and play as part of the care
• Allow time for the child to get familiar 
with the surroundings
4
Encountering the Child
Listen to and encourage the child
• E.g. by directly asking them how 
they feel
• Complement the child in an 
honest way by addressing the 
uniqueness of the individual child
5
Counselling the Parents
6
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2
Counselling the Parents
• Health care professionals 
provide valuable information to 
parents about immunization
• Parents are more likely to 
vaccinate their child when they 
are educated on vaccines and 
preventable disease
7
Counselling the Parents
• Discuss with parents 
about their concerns, they 
should be able to ask 
anything
• Create an open 
environment for 
conversation
Inform the parents on the: 
• disease associated with the vaccine and 
the vaccination coverage in different 
countries
• vaccines that are administered
• vaccination schedule
• adverse reactions and possible 
• symptoms that occur from the vaccine
• vaccine administration procedure
• holding positions
• pain management
8
Correct Holding Positions
9
Correct Holding Positions
• Instruct the parents and collaborate 
with them on the best holding position
• Create a safe and comfortable position
• Inappropriate holding technique might 
result in the child moving
• The needle can move inside the tissue 
which can create pain for the child
• Vaccine might end up in the wrong 
compartment
• Risk of accidents involving the needle
10
Recommendations on How to Hold the Child
• Holding position for an infant
• Instruct the parent to hold the child on their lap while placing the child in a hug like 
position
• With their other hand instruct them to hold the feet down
• Ask them to hold the child gently but firmly to create a secure feeling and prevent 
them from moving
• Holding position for an older child
• Instruct the parent to hold the child in a hug like position on their lap while securing 
the child’s arms with their hands.
• The parent can anchor the child’s feet firmly between their own legs
11
Vaccine Administration
12
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3
Vaccine Administration
• Every vaccine has specific, individual instructions for the preparation, 
that the health care worker should get familiar with
• For example, the MRR vaccine is prepared accordingly:
1. Insert the liquid from the syringe with a needle into the injection bottle. 
2. Gently shake the bottle until the powder has dissolved into the liquid and the 
suspension is turbid and of light color. 
3. Immediately after the suspension is ready, draw it into a new syringe and shake 
the syringe gently. 
4. Check the content of the syringe and shake rapidly if a gel like phase is still visible. 
5. Swap in a clean needle and administer right away. 
13
Vaccine Administration
• Vaccines are administered either 
via nasal-, oral-, subcutaneous- or 
intramuscular route
• Intramuscular injection is given to 
the upper-outer part of the thigh 
muscle, or to the deltoid muscle, 
depending on the age and size of 
the child
14
Intramuscular Injection Administration (1/2)
• Once the vaccine is prepared, it 
should be administered immediately
• The injection site area isn’t required 
to be cleansed, but if done so, 
needed to let dry completely prior 
the injection
• Take a firm grip of the the muscle 
and insert the needle in 60 to 90-
degree angle
15
Intramuscular Injection Administration (2/2)
• Next hold the needle steady with the other hand while making sure 
the needle is not in a blood vessel 
• Aspirating isn’t required but is not harmful
• Slowly administer the vaccine
• Remove the needle and press the injection site with a clean pad for 
couple of seconds
16
Ending the Visit
17
Ending the Visit
• It is important that the child will 
leave with a positive experience
• Comfort and encourage the child 
without adding too much emphasis 
on the pain they are experiencing
• Sometimes it is also necessary to 
comfort the parents, since seeing their 
child in pain can be uncomfortable
18
